Conclusion: Our results support a revision of the NeuPSIG recommendations for the pharmacotherapy of neuropathic pain. Inadequate response to drug treatments constitutes a substantial unmet need in patients with neuropathic pain. Modest efficacy, large placebo responses, heterogeneous diagnostic criteria, and poor phenotypic profiling probably account for moderate trial outcomes and should be taken into account in future studies.
PubMed 25575710 ↗Pregabalin
Also known as Lyrica
The short answer. Most people who report on Pregabalin say it did not help (only 29% of 52 positive). It is most often used for anxiety: 76% of 33 reports say that improved. It is well studied — 387 meta-analyses on PubMed. The most common complaint is dependence.
From 102 mentions in total — the rest didn't say how it went and aren't counted.
What Pregabalin does, according to users
Of the people who reported each effect, the share who said it got better.
4 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 387 meta-analyses on PubMed ↗ · 599 randomized trials ↗
Conclusion: Pure overdoses of gabapentinoids appeared to be relative safe but can become lethal (pregabalin > gabapentin) in mixture with other psychoactive drugs, especially opioids again and sedatives. Based upon these results, we compared the addiction risks of gabapentin and pregabalin with those of traditional psychoactive substances and recommend that in patients with a history of SUD, gabapentinoids should be avoided or if indispensable, administered with caution by using a strict therapeutic and prescription monitoring.
PubMed 28988943 ↗Conclusion: To our knowledge, this is the largest contemporary review of pharmacological agents for the treatment of generalised anxiety disorder by use of network analysis. There are several effective treatment choices for generalised anxiety disorder across classes of medication. The failure of initial pharmacological therapy might not be a reason to abandon a pharmacological treatment strategy.
PubMed 30712879 ↗Conclusion: Pregabalin supplementation benefits to pain control after septorhinoplasty.
PubMed 36048296 ↗634 human trials on ClinicalTrials.gov test Pregabalin — 379 completed, 56 recruiting now. See all on ClinicalTrials.gov ↗
- Co-analgesic Effects of Dexamethasone and Pregabalin After Lumbar Slipped Disc Surgery · Patients Undergoing a Lumbar Slipped Disc Surgery · 2017
- Study on the Efficacy and Safety of Tongluo Kaibi Tablets in the Treatment of Fibromyalgia Syndrome · Fibromyalgia Syndrome · 2026
- A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats · Hot Flashes · 2026
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
Pregabalin is a Schedule V controlled substance in the US. DEA controlled-substance list ↗
The current US prescription label has no boxed warning.
8 recalls of products named for Pregabalin. Most recent:
- 2024-06-12 · Class III: Presence of Foreign Tablets/Capsules: Complaint received from a re-packager, American Health Packaging (AHP), where a foreign tablet was discovered in one… record ↗
- 2022-01-12 · Class II: Failed Tablet/Capsule Specifications: Out of Specification results for particle Size Distribution and Bulk Density of the Active Pharmaceutical Ingredient. record ↗
- 2021-06-02 · Class II: CGMP Deviations: Intermittent exposure to temperature excursion during storage. record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
270,564 adverse-event reports mention Pregabalin. Most often reported:
- Drug ineffective · 26,976
- Pain · 26,330
- Fatigue · 15,635
- Dizziness · 14,846
- Nausea · 14,508
- Off label use · 13,799
Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗
LiverTox rates Pregabalin C — a probable rare cause of liver injury (3–12 published cases). LiverTox entry ↗
NIH has funded 15 research projects with Pregabalin in the title, $22,258,561 in total (1999–2025). NIH RePORTER ↗
Plain-language guides from the US government: MedlinePlus: Pregabalin ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“My silver bullet for sleep is GHB (2.5ml) + a calcium channel blocker...pregabalin (50-75mg)”
“I’ve since trialled Pregabalin and currently been on Lamotrigine for 7 weeks and zero improvement.”
“Pregabaline helps but I think my dose is too low I take between 200-300 and I’m waiting for my appointment and see if it will get increased.”
“I am prescribed pregablin, one 25mg tablet at night. But I can't focus while on that, so can only take it at night.”
Top discussions (5)
- How I reversed my epigenetic age by 10 years ↗
- Most effective and profoundly noticeable substance for Social Anxiety ↗
- I am begging someone to find me SOMETHING to take away unexplained emotional pain/distress that I’ve had for 18 months and has left professionals baffled. Please save my life guys. ↗
- NAC solves my anhedonia, why? ↗
- Crushing tasks, and no procrastination on BENZOS?! ↗
Other options for anxiety
Sources
- User reports: 102 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA drug label (DailyMed) ↗
- FDA adverse-event reports (FAERS) ↗
- FDA recalls ↗
- US DEA ↗
- LiverTox (NIH) ↗
- MedlinePlus (NIH) ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate